Exciting talk by All-Star @MayoRadOnc resident Daniel Ebner on stereotactic proton therapy and immunotherapy for recurrent H&N cancer at @PTCOGNA 9th Annual Meeting!
Only managed to find about half of team @radonc_OU but we’ve got residents, therapy, med phys, and clinical faculty all repping strong this year! #ASTRO23
Calling all rad oncs, educators, and more! Join us for our next @RadiologyACR Webinar:
Diversity, Equity, and Inclusion in Radiation Oncology
Aug. 16 | 5–6:30pm ET
Link to register: https://t.co/HMSfubt1zL
Great podcast that tells you everything you need to know about how to radiate recurrent/refractory lymphoma in the setting of transplant or CAR-T.
Direct link at: https://t.co/CpdmyjBrQA
@belinda_campbe @MarioLevis82 @MayoCancerCare@ILROGTeam
🚨@Haematologica: Consolidative RT (cRT) vs observation for residual disease/FDG-activity on day+30 post-CART?
cRT alters pattern of relapse➡️ improves local recurrence-free survival (2yr 100% vs 31%)➡️ improves progression-free survival (2yr 73% vs 37%)
https://t.co/Vya8b9eyQ1
Congratulations to our resident @AaronBushMD for being selected to be apart of Mayo Clinic GME's Clinician Educator Pathway from a very competitive pool. This is a huge achievement and look forward to seeing all the great things you will accomplish this year! #radonc@ARRO_org
OU Health Stephenson Cancer Center Researcher Leads Global Study Investigating Immunotherapy Drugs for People Living With Cancer and HIV
https://t.co/S166l7tFU2
A #radonc away rotation @MayoClinicFlorida means a month to explore the best of Jacksonville, FL: our campus, outstanding faculty, & what residency in sunshine state really feels like! 🌴☀️🌊
🚨 Apply soon via VSLO or email [email protected]#match2024🚨